Neuraxis NRXS
NYSE NRXS
$5.50 -0.25 (-4.35%)
At close: Nov 13, 2026 · 4:00 PM EST

Neuraxis (NRXS) Current Deferred Revenue (2025 - 2026)

Updated

Neuraxis (NRXS) recorded Current Deferred Revenue of $23,829 in Q3 2026.

Analysis

Neuraxis (NRXS) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Neuraxis reported Current Deferred Revenue of $28,660.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Neuraxis 75.94 Mn 51.10 Mn 1.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23,829.00
Dec 31, 2025 28,660.00
API Access

Neuraxis Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NRXS&period=max&api_key=YOUR_API_KEY